Dalfampridine (brand name: Ampyra) acts as a K channel inhibitor which potentiates neuron conduction. 
– used to improve walking in MS patients
– It is known to lower the seizure threshold and is best avoided in patients with epilepsy 
– It is renally cleared and cannot be used in patients with chronic kidney disease